BDBM548014 3-(4-((S)-2-(3-ethylisoxazole-4-carboxamido)-2-((1r,4S)-4- (trifluoromethyl)cyclohexyl)acetamido)phenyl)-2,4-dimethylpyridine 1-oxide::WO2022091056, Example 8

SMILES CCc1nocc1C(=O)N[C@H](C(=O)Nc1ccc(-c2c(C)cc[n+]([O-])c2C)cc1)[C@H]1CC[C@@H](C(F)(F)F)CC1

InChI Key InChIKey=RMGKRDBEMKRZFJ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 548014   

TargetInterleukin-17 receptor A/(Human)
Novartis

WIPO
LigandChemical structure of BindingDB Monomer ID 548014BDBM548014(3-(4-((S)-2-(3-ethylisoxazole-4-carboxamido)-2-((1...)
Affinity DataIC50: 41nMAssay Description: Dilutions of test compounds in DMSO are plated onto white low-volume 384-well plates (Greiner, #784075). Specifically, solutions of graded concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2022
Entry Details
WIPO WO2022091056